Table 4.

Adverse events

Type of Adverse Events	Clinical Adverse Events* N = 103 n (%)	Laboratory Adverse Events** N = 103 n (%)
Any adverse events	4 (3.9)	8 (7.8)
Serious adverse events	3 (2.9)	1 (0.9)
Serious adverse events leading to discontinuation	2 (1.9)	1 (0.9)

* Clinical adverse events include: bronchopneumonia; skin reaction; respiratory failure; and abdominal pain

**Laboratory adverse events include: increase in aspartate aminotransferase, alanine aminotransferase, blood alkaline phosphatase, blood bilirubin, gamma glutamyltransferase; leukopenia; hyperbilirubinemia; and hypokalemia.